PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAcadia Pharmaceuticals
Acadia Pharmaceuticals(ACAD)
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
NuplazidPimavanserin2016-04-292024-2038
Parkinson disease
,
Hallucinations
,
Schizophrenia spectrum and other psychotic disorders
DaybueTrofinetide2023-03-102032-2040
Rett syndrome
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pimavanserin
tourette syndrome
,
tardive dyskinesia
,
syndrome
,
impulse control disruptive and conduct disorders
,
alzheimer disease
,
aggression
,
dyskinesias
,
psychomotor agitation
,
healthy volunteers/patients
,
behavior
,
movement disorders
,
affect
,
schizophrenia
,
depression
,
depressive disorder
,
major depressive disorder
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
parkinson disease
,
psychotic disorders
,
mental disorders
,
sleep initiation and maintenance disorders
,
post-traumatic stress disorders
,
neurodegenerative diseases
,
traumatic stress disorders
,
dementia
,
hallucinations
,
lewy body disease
,
delusions
Trofinetide
brain injuries
,
traumatic brain injuries
,
brain concussion
,
post-concussion syndrome
,
fragile x syndrome
,
rett syndrome
,
syndrome
Fluorodopa f-18
squamous cell carcinoma of head and neck
,
idiopathic pulmonary fibrosis
,
healthy volunteers/patients
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
stomach neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
esophageal squamous cell carcinoma
Glutamic acid
schizophrenia
,
psychotic disorders
Carbetocin
prader-willi syndrome
Aspartame
metabolic bone diseases
,
t-cell lymphoma
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
brain diseases
,
hepatic encephalopathy
,
healthy volunteers/patients
,
recurrence
,
carcinoma
,
anemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
asthma
,
rare diseases
,
cystinosis
,
multiple myeloma
,
plasma cell neoplasms
,
neoplasms
,
leukemia
,
lymphoma
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
dyslipidemias
,
psoriasis
,
nasal polyps
,
bone fractures
,
stomatitis
,
mucositis
,
vasculitis
,
anti-neutrophil cytoplasmic antibody-associated vasculitis
,
inborn urea cycle disorders
,
heart failure
,
left ventricular dysfunction
,
cardiovascular diseases
,
hypercholesterolemia
,
hyperlipidemias
,
hidradenitis suppurativa
D-glutamate
colorectal neoplasms
,
breast neoplasms
,
lung neoplasms
,
non-small-cell lung carcinoma
,
neoplasms
,
neoplasm metastasis
,
head and neck neoplasms
,
recurrence
,
carcinoma
,
small cell lung carcinoma
,
adenocarcinoma of lung
,
bronchiolo-alveolar adenocarcinoma
Fludeoxyglucose f-18
multiple myeloma
,
head and neck neoplasms
,
renal cell carcinoma
,
sarcoidosis
,
pulmonary sarcoidosis
,
castration-resistant prostatic neoplasms
,
adenocarcinoma
,
prostatic neoplasms
,
relapsing-remitting multiple sclerosis
,
recurrence
,
hypertension
,
abdominal aortic aneurysm
,
aneurysm
,
aortic aneurysm
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use